1-((2R,3R)-3-(4-(4-CYANOPHENYL)THIAZOL-2-YL)-2-(2,5-DIFLUOROPHENYL)-2-HYDROXYBUTYL)-4-METHYL-1H-1,2,4-TRIAZOL-4-IUM
UNII 69LH96Y824
Substance Identification & Data
This profile provides standardized clinical and technical data for 1-((2r,3r)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-methyl-1h-1,2,4-triazol-4-ium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 69LH96Y824.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H20F2N5OS CWEVAIZNVINYDD-NPMXOYFQSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 1-((2r,3r)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-methyl-1h-1,2,4-triazol-4-ium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.